Impact of the spread of COVID-19 on business and performance
First written in FY2020. 5 of 13 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2025: 4 of 13 companies on the "Worse" side.
10 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「Although the normalization of socioeconomic activity progressed and the economy gradually recovered, including the reclassification of COVID-19 under the Infectious Diseases Control Law to Category V,」
While the reclassification under the Infectious Diseases Control Law and the normalization of socioeconomic activity progressed, the disclosure continued to state that uncertainty remained in the economic environment. - FY2024-Q1MitigatedAnnual report
「Although the normalization of socioeconomic activity progressed and the economy gradually recovered, including the reclassification of COVID-19 under the Infectious Diseases Control Law to Category V,」
The disclosure described the reclassification under the Infectious Diseases Control Law and the normalization of socioeconomic activity, indicating that the impact of restrictions on activities due to the infectious disease was easing compared with before. - FY2023MitigatedAnnual report
「Operating revenue increased by ¥1,133 million, or 9.9%, from the previous consolidated fiscal year. Although the transportation business continued to be affected by COVID-19, the impact was reduced from the previous fiscal year due to the easing of restrictions on activities and other factors.」
Although the impact of the infectious disease on the business and operating performance remained, the impact on the transportation business was reduced from the previous fiscal year as restrictions on activities were eased, and revenue recovery progressed. - FY2023-Q3RestatedAnnual report
「Although it remains difficult to reasonably quantify the impact of COVID-19, the situation has gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. Depending on future developments, the Group's financial position and operating performance may be affected.」
Although it remains difficult to reasonably quantify the impact of the infectious disease and the possibility of an impact on operating performance remains, the disclosure continued to state that the situation was recovering, partly due to the wider availability of vaccinations. - FY2023-Q2RestatedAnnual report
「Although it remains difficult to reasonably quantify the impact of COVID-19, the situation has gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. Depending on future developments, the Group's financial position and operating performance may be affected.」
Although it remains difficult to reasonably quantify the impact of the infectious disease and the possibility of an impact on operating performance remains, the disclosure continued to state that the situation was recovering, partly due to the wider availability of vaccinations. - FY2023-Q1RestatedAnnual report
「Although it remains difficult to reasonably quantify the impact of COVID-19, the situation has gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. Depending on future developments, the Group's financial position and operating performance may be affected.」
Although it remains difficult to reasonably quantify the impact of the infectious disease and the possibility of an impact on operating performance remains, the disclosure continued to state that the situation was recovering, partly due to the wider availability of vaccinations. - FY2022Recovery, but still below pre-pandemic levelsAnnual report
「Although operating performance during the consolidated fiscal year exceeded that of the previous consolidated fiscal year, it remained below the level before the spread of COVID-19,」
The disclosure explained that operating performance recovered from the previous fiscal year despite the impact of the infectious disease, but had not returned to pre-pandemic levels. - FY2022-Q3RestatedAnnual report
「Although it remains difficult to reasonably quantify the impact of COVID-19, the situation has gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. Depending on future developments, the Group's financial position and operating performance may be affected.」
Although it remains difficult to reasonably quantify the impact of the infectious disease and the possibility of an impact on operating performance remains, the disclosure continued to state that the situation was recovering from the same period of the previous year, partly due to the wider availability of vaccinations. - FY2022-Q1MitigatedAnnual report
「Although it remains difficult to reasonably quantify the impact of COVID-19, the situation has gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. Depending on future developments, the Group's financial position and operating performance may be affected.」
Although it remains difficult to reasonably quantify the impact of COVID-19 and the possibility of an impact on operating performance remains, the disclosure stated that the situation had gradually begun to recover from the same period of the previous year, partly due to the wider availability of vaccinations. - FY2021-Q3WorsenedAnnual report
「Regarding the outlook, the impact of fewer opportunities for travel, including changes in the behaviour of companies and individuals based on the new lifestyle, is expected to continue from the third-quarter consolidated accounting period onward. However, depending on future developments, the Group's financial position and operating performance may be affected.」
The decline in users and impact on operating performance due to requests to refrain from going out and other measures continued, and the impact of the new lifestyle and fewer opportunities for travel is also expected to continue from the third quarter onward. - FY2021-Q2MaterialisedAnnual report
「In addition, the Group's operating performance has been affected by a substantial decline in users of railways, buses and taxis following requests to refrain from going out due to the spread of COVID-19. Following the lifting of the state of emergency in May 2020, the situation has gradually begun to recover.」
Although the substantial decline in users and the impact on operating performance caused by the spread of COVID-19 continued, the disclosure stated that the situation had gradually begun to recover following the lifting of the state of emergency. - FY2021-Q1MaterialisedAnnual report
「In addition, the Group's performance has been affected by a substantial decline in users of railways, buses and taxis following requests to refrain from going out due to the spread of COVID-19.」
The decline in users due to COVID-19 and its impact on operating performance actually occurred during the quarter. The possibility that future developments may affect the Group's financial position and operating performance also remains. - FY2020First statedAnnual report
「If an infectious disease, including COVID-19, occurs and spreads, the Group's core businesses, transportation, real estate and distribution, may experience a decline in users due to significant changes in lifestyles, as well as business contraction or suspension due to staff shortages resulting from employee infections. / The impact of the spread of COVID-19 on operating performance during the consolidated fiscal year was an estimated ¥270 million decrease in operating revenue and an estimated ¥210 million decrease in operating income.」
COVID-19 was disclosed independently as a major risk for the first time, with the possibility of declining users, staff shortages, business contraction and suspension indicated. An estimated ¥270 million decrease in operating revenue and ¥210 million decrease in operating income, mainly in FY2020-Q4, actually occurred.